The next wave of transcatheter heart valves is here
Edwards Lifesciences’ EVOQUE gained US Food and Drug Administration (FDA) approval in February 2024, making it the first transcatheter tricuspid …
Edwards Lifesciences’ EVOQUE gained US Food and Drug Administration (FDA) approval in February 2024, making it the first transcatheter tricuspid …
Immunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a sarcopenia therapy, leveraging the …
DexCom has released its second quarter (Q2) financials reporting a 15% growth in revenue to $1bn, up from $871.3m in …
Molecular imaging medical device company Positron has announced the launch of the NeuSight PET-CT 3D 64 slice scanner in the …
Perosphere Technologies, a developer of next-generation coagulation diagnostics, has signed an exclusive agreement with CoRRect Medical for the distribution of …
GE Healthcare and Amazon Web Services (AWS) are teaming up to build new generative AI models that can analyse complex …
Hologic has closed the acquisition of UK-based breast cancer surgery technologies developer Endomagnetics (Endomag) for approximately $310m. The deal between the …
The Medical University of South Carolina (MUSC) Hollings Cancer Center in the US is set to deploy MOLLI Surgical's advanced …
A significant evolution in upper limb prosthetics has been made through Heriot-Watt University’s inaugural DeepTech LaunchPad programme in Scotland. During the …
Deepc has closed a $13m Series A extension round, bringing the German company’s total funding to $30m. The round was co-led …
Imperative Care has announced positive data from a study of its Zoom reperfusion system, suggesting reduced rates of rescue therapy …
SoundHealth has launched SONU, an AI-enabled wearable device for at-home treatment of nasal congestion due to allergic and non-allergic rhinitis …
European device company TRiCares has raised $50m in a Series D financing round to develop its transfemoral tricuspid heart valve …
Kestra Medical Technologies has secured $196m in an oversubscribed funding round to boost the commercialisation of the ASSURE wearable cardioverter …
Edwards Lifesciences has announced strategic acquisitions of JenaValve Technology and Endotronix to expand its structural heart portfolio. These investments aim to …